CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Private Placement	Pre-Funded Warrants Private Placement	Common Stock	Common Stock Private Placement	Additional Paid-In Capital	Additional Paid-In Capital Private Placement	Additional Paid-In Capital Pre-Funded Warrants Private Placement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 170,475			$ 22		$ 226,580			$ (95)	$ (56,032)
Beginning Balance, Shares at Dec. 31, 2022				21,920,402
Exercise of common stock options, Shares				232
Stock-based compensation expense	2,646					2,646
Unrealized gain (loss) on available-for-sale investments, net of tax	104								104
Net Income (Loss)	(12,756)									(12,756)
Ending Balance at Mar. 31, 2023	160,469			$ 22		229,226			9	(68,788)
Ending Balance, Shares at Mar. 31, 2023				21,920,634
Beginning Balance at Dec. 31, 2022	170,475			$ 22		226,580			(95)	(56,032)
Beginning Balance, Shares at Dec. 31, 2022				21,920,402
Unrealized gain (loss) on available-for-sale investments, net of tax	(332)
Net Income (Loss)	(26,670)
Ending Balance at Jun. 30, 2023	149,184			$ 22		232,291			(427)	(82,702)
Ending Balance, Shares at Jun. 30, 2023				22,068,660
Beginning Balance at Mar. 31, 2023	160,469			$ 22		229,226			9	(68,788)
Beginning Balance, Shares at Mar. 31, 2023				21,920,634
Exercise of common stock options	379					379
Exercise of common stock options, Shares				148,026
Stock-based compensation expense	2,686					2,686
Unrealized gain (loss) on available-for-sale investments, net of tax	(436)								(436)
Net Income (Loss)	(13,914)									(13,914)
Ending Balance at Jun. 30, 2023	149,184			$ 22		232,291			(427)	(82,702)
Ending Balance, Shares at Jun. 30, 2023				22,068,660
Beginning Balance at Dec. 31, 2023	121,195			$ 23		237,675			(83)	(116,420)
Beginning Balance, Shares at Dec. 31, 2023				22,522,644
Exercise of common stock options	79					79
Exercise of common stock options, Shares				20,277
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax	(166)					(166)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares				94,618
Stock-based compensation expense	3,344					3,344
Unrealized gain (loss) on available-for-sale investments, net of tax	13								13
Net Income (Loss)	(16,486)									(16,486)
Ending Balance at Mar. 31, 2024	107,979			$ 23		240,932			(70)	(132,906)
Ending Balance, Shares at Mar. 31, 2024				22,637,539
Beginning Balance at Dec. 31, 2023	$ 121,195			$ 23		237,675			(83)	(116,420)
Beginning Balance, Shares at Dec. 31, 2023				22,522,644
Exercise of common stock options, Shares	30,875
Unrealized gain (loss) on available-for-sale investments, net of tax	$ 64
Net Income (Loss)	(35,284)
Ending Balance at Jun. 30, 2024	216,058			$ 31		367,750			(19)	(151,704)
Ending Balance, Shares at Jun. 30, 2024				30,966,255
Beginning Balance at Mar. 31, 2024	107,979			$ 23		240,932			(70)	(132,906)
Beginning Balance, Shares at Mar. 31, 2024				22,637,539
Issuance of common stock in private placement, net of issuance costs		$ 66,637			$ 8		$ 66,629
Issuance of common stock in private placement, net of issuance costs, Shares					8,235,000
Issuance of pre-funded warrants in private placement, net of issuance costs			$ 57,122					$ 57,122
Exercise of common stock options	11					11
Exercise of common stock options, Shares				10,598
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax	(510)					(510)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares				83,118
Stock-based compensation expense	3,566					3,566
Unrealized gain (loss) on available-for-sale investments, net of tax	51								51
Net Income (Loss)	(18,798)									(18,798)
Ending Balance at Jun. 30, 2024	$ 216,058			$ 31		$ 367,750			$ (19)	$ (151,704)
Ending Balance, Shares at Jun. 30, 2024				30,966,255